| 1 | [SID56422357] | Active | Potency | 2.5119 | qHTS for Inhibitors of Polymerase Eta [AID588591, Type: confirmatory] | DNA polymerase eta [Homo sapiens] [gi:5729982] |  View X | Row No. | 1 | | Structure |
| | Substance | | | SID | 56422357 | | CID | 25102417 | | Outcome | Active | | Potency | 2.5119 [uM] | | BioAssay | qHTS for Inhibitors of Polymerase Eta | | AID | 588591 | | BioAssay type | confirmatory | | Target | DNA polymerase eta [Homo sapiens] [gi:5729982] | | PubMed | | | Data Table |  |
|
| 2 | [SID56422357] | Active | Potency | 2.5119 | qHTS for Inhibitors of Polymerase Eta [AID588591, Type: confirmatory] | DNA polymerase eta [Homo sapiens] [gi:5729982] |  View X | Row No. | 2 | | Structure |
| | Substance | | | SID | 56422357 | | CID | 25102417 | | Outcome | Active | | Potency | 2.5119 [uM] | | BioAssay | qHTS for Inhibitors of Polymerase Eta | | AID | 588591 | | BioAssay type | confirmatory | | Target | DNA polymerase eta [Homo sapiens] [gi:5729982] | | PubMed | | | Data Table |  |
|
| 3 | [SID56422357] | Active | Potency | 3.9811 | qHTS Assay for the Inhibitors of L3MBTL1 [AID485360, Type: confirmatory] | lethal(3)malignant brain tumor-like protein 1 isoform I [Homo sapiens] [gi:117938328] |  View X | Row No. | 3 | | Structure |
| | Substance | | | SID | 56422357 | | CID | 25102417 | | Outcome | Active | | Potency | 3.9811 [uM] | | BioAssay | qHTS Assay for the Inhibitors of L3MBTL1 | | AID | 485360 | | BioAssay type | confirmatory | | Target | lethal(3)malignant brain tumor-like protein 1 isoform I [Homo sapiens] [gi:117938328] | | PubMed | | | Data Table |  |
|
| 4 | [SID56422357] | Active | Potency | 3.9811 | qHTS Assay for the Inhibitors of L3MBTL1 [AID485360, Type: confirmatory] | lethal(3)malignant brain tumor-like protein 1 isoform I [Homo sapiens] [gi:117938328] |  View X | Row No. | 4 | | Structure |
| | Substance | | | SID | 56422357 | | CID | 25102417 | | Outcome | Active | | Potency | 3.9811 [uM] | | BioAssay | qHTS Assay for the Inhibitors of L3MBTL1 | | AID | 485360 | | BioAssay type | confirmatory | | Target | lethal(3)malignant brain tumor-like protein 1 isoform I [Homo sapiens] [gi:117938328] | | PubMed | | | Data Table |  |
|
| 5 | [SID56422357] | Active | IC50 | 5.677 | Dose Response confirmation of uHTS hits for Scp-1 phosphatase using a colorimetric assay [AID540297, Type: confirmatory] | carboxy-terminal domain RNA polymerase II polypeptide A small phosphatase 1 isoform 1 [Homo sapiens] [gi:10864009] |  View X | Row No. | 5 | | Structure |
| | Substance | | | SID | 56422357 | | CID | 25102417 | | Outcome | Active | | IC50 | 5.677 [uM] | | BioAssay | Dose Response confirmation of uHTS hits for Scp-1 phosphatase using a colorimetric assay | | AID | 540297 | | BioAssay type | confirmatory | | Target | carboxy-terminal domain RNA polymerase II polypeptide A small phosphatase 1 isoform 1 [Homo sapiens] [gi:10864009] | | PubMed | | | Data Table |  |
|
| 6 | [SID56422357] | Active | IC50 | 5.95 | Dose response confirmation of uHTS inhibitor hits of SUMO1-mediated protein-protein interactions using a fluorescence resonance energy transfer assay [AID624383, Type: confirmatory] | SUMO-1 [Homo sapiens] [gi:1762973] |  View X | Row No. | 6 | | Structure |
| | Substance | | | SID | 56422357 | | CID | 25102417 | | Outcome | Active | | IC50 | 5.95 [uM] | | BioAssay | Dose response confirmation of uHTS inhibitor hits of SUMO1-mediated protein-protein interactions using a fluorescence resonance energy transfer assay | | AID | 624383 | | BioAssay type | confirmatory | | Target | SUMO-1 [Homo sapiens] [gi:1762973] | | PubMed | | | Data Table |  |
|
| 7 | [SID56422357] | Active | Potency | 8.9125 | qHTS for Inhibitors of Polymerase Iota [AID588590, Type: confirmatory] | DNA polymerase iota [Homo sapiens] [gi:154350220] |  View X | Row No. | 7 | | Structure |
| | Substance | | | SID | 56422357 | | CID | 25102417 | | Outcome | Active | | Potency | 8.9125 [uM] | | BioAssay | qHTS for Inhibitors of Polymerase Iota | | AID | 588590 | | BioAssay type | confirmatory | | Target | DNA polymerase iota [Homo sapiens] [gi:154350220] | | PubMed | | | Data Table |  |
|
| 8 | [SID56422357] | Active | Potency | 8.9125 | qHTS for Inhibitors of Polymerase Iota [AID588590, Type: confirmatory] | DNA polymerase iota [Homo sapiens] [gi:154350220] |  View X | Row No. | 8 | | Structure |
| | Substance | | | SID | 56422357 | | CID | 25102417 | | Outcome | Active | | Potency | 8.9125 [uM] | | BioAssay | qHTS for Inhibitors of Polymerase Iota | | AID | 588590 | | BioAssay type | confirmatory | | Target | DNA polymerase iota [Homo sapiens] [gi:154350220] | | PubMed | | | Data Table |  |
|
| 9 | [SID56422357] | Active | IC50 | 9.26 | Dose response confirmation of DNMT1 inhibitors in a Fluorescent Molecular Beacon assay [AID602386, Type: confirmatory] | DNA (cytosine-5)-methyltransferase 1 isoform b [Homo sapiens] [gi:4503351] |  View X | Row No. | 9 | | Structure |
| | Substance | | | SID | 56422357 | | CID | 25102417 | | Outcome | Active | | IC50 | 9.26 [uM] | | BioAssay | Dose response confirmation of DNMT1 inhibitors in a Fluorescent Molecular Beacon assay | | AID | 602386 | | BioAssay type | confirmatory | | Target | DNA (cytosine-5)-methyltransferase 1 isoform b [Homo sapiens] [gi:4503351] | | PubMed | | | Data Table |  |
|
| 10 | [SID56422357] | Active | IC50 | 9.26 | Dose response confirmation of DNMT1 inhibitors in a Fluorescent Molecular Beacon assay [AID602386, Type: confirmatory] | DNA (cytosine-5)-methyltransferase 1 isoform b [Homo sapiens] [gi:4503351] |  View X | Row No. | 10 | | Structure |
| | Substance | | | SID | 56422357 | | CID | 25102417 | | Outcome | Active | | IC50 | 9.26 [uM] | | BioAssay | Dose response confirmation of DNMT1 inhibitors in a Fluorescent Molecular Beacon assay | | AID | 602386 | | BioAssay type | confirmatory | | Target | DNA (cytosine-5)-methyltransferase 1 isoform b [Homo sapiens] [gi:4503351] | | PubMed | | | Data Table |  |
|
| 11 | [SID56422357] | Active | IC50 | 11 | Dose response confirmation of uHTS RPN11 inhibitor hits in a Fluorescence Polarization assay [AID602368, Type: confirmatory] | PSMD14 protein [Homo sapiens] [gi:16306916] |  View X | Row No. | 11 | | Structure |
| | Substance | | | SID | 56422357 | | CID | 25102417 | | Outcome | Active | | IC50 | 11 [uM] | | BioAssay | Dose response confirmation of uHTS RPN11 inhibitor hits in a Fluorescence Polarization assay | | AID | 602368 | | BioAssay type | confirmatory | | Target | PSMD14 protein [Homo sapiens] [gi:16306916] | | PubMed | | | Data Table |  |
|
| 12 | [SID56422357] | Active | Potency | 11.2202 | qHTS Assay for Inhibitors of BAZ2B [AID504333, Type: confirmatory] | bromodomain adjacent to zinc finger domain 2B [Homo sapiens] [gi:6683500] |  View X | Row No. | 12 | | Structure |
| | Substance | | | SID | 56422357 | | CID | 25102417 | | Outcome | Active | | Potency | 11.2202 [uM] | | BioAssay | qHTS Assay for Inhibitors of BAZ2B | | AID | 504333 | | BioAssay type | confirmatory | | Target | bromodomain adjacent to zinc finger domain 2B [Homo sapiens] [gi:6683500] | | PubMed | | | Data Table |  |
|
| 13 | [SID56422357] | Active | Potency | 17.7828 | qHTS for Inhibitors of Polymerase Kappa [AID588579, Type: confirmatory] | DNA polymerase kappa [Homo sapiens] [gi:7705344] |  View X | Row No. | 13 | | Structure |
| | Substance | | | SID | 56422357 | | CID | 25102417 | | Outcome | Active | | Potency | 17.7828 [uM] | | BioAssay | qHTS for Inhibitors of Polymerase Kappa | | AID | 588579 | | BioAssay type | confirmatory | | Target | DNA polymerase kappa [Homo sapiens] [gi:7705344] | | PubMed | | | Data Table |  |
|
| 14 | [SID56422357] | Active | Potency | 17.7828 | qHTS for Inhibitors of Polymerase Kappa [AID588579, Type: confirmatory] | DNA polymerase kappa [Homo sapiens] [gi:7705344] |  View X | Row No. | 14 | | Structure |
| | Substance | | | SID | 56422357 | | CID | 25102417 | | Outcome | Active | | Potency | 17.7828 [uM] | | BioAssay | qHTS for Inhibitors of Polymerase Kappa | | AID | 588579 | | BioAssay type | confirmatory | | Target | DNA polymerase kappa [Homo sapiens] [gi:7705344] | | PubMed | | | Data Table |  |
|
| 15 | [SID56422357] | Active | IC50 | 18.4 | Dose Response validation of uHTS RPN11 inhibitor hits using a MMP-2 Fluorescence assay [AID602361, Type: confirmatory] | 72 kDa type IV collagenase isoform a preproprotein [Homo sapiens] [gi:11342666] |  View X | Row No. | 15 | | Structure |
| | Substance | | | SID | 56422357 | | CID | 25102417 | | Outcome | Active | | IC50 | 18.4 [uM] | | BioAssay | Dose Response validation of uHTS RPN11 inhibitor hits using a MMP-2 Fluorescence assay | | AID | 602361 | | BioAssay type | confirmatory | | Target | 72 kDa type IV collagenase isoform a preproprotein [Homo sapiens] [gi:11342666] | | PubMed | | | Data Table |  |
|
| 16 | [SID56422357] | Active | IC50 | 18.4 | Dose Response validation of uHTS RPN11 inhibitor hits using a MMP-2 Fluorescence assay [AID602361, Type: confirmatory] | 72 kDa type IV collagenase isoform a preproprotein [Homo sapiens] [gi:11342666] |  View X | Row No. | 16 | | Structure |
| | Substance | | | SID | 56422357 | | CID | 25102417 | | Outcome | Active | | IC50 | 18.4 [uM] | | BioAssay | Dose Response validation of uHTS RPN11 inhibitor hits using a MMP-2 Fluorescence assay | | AID | 602361 | | BioAssay type | confirmatory | | Target | 72 kDa type IV collagenase isoform a preproprotein [Homo sapiens] [gi:11342666] | | PubMed | | | Data Table |  |
|
| 17 | [SID56422357] | Active | IC50 | 18.4 | Dose Response validation of uHTS RPN11 inhibitor hits using a MMP-2 Fluorescence assay [AID602361, Type: confirmatory] | 72 kDa type IV collagenase isoform a preproprotein [Homo sapiens] [gi:11342666] |  View X | Row No. | 17 | | Structure |
| | Substance | | | SID | 56422357 | | CID | 25102417 | | Outcome | Active | | IC50 | 18.4 [uM] | | BioAssay | Dose Response validation of uHTS RPN11 inhibitor hits using a MMP-2 Fluorescence assay | | AID | 602361 | | BioAssay type | confirmatory | | Target | 72 kDa type IV collagenase isoform a preproprotein [Homo sapiens] [gi:11342666] | | PubMed | | | Data Table |  |
|
| 18 | [SID56422357] | Active | Potency | 19.9526 | HTS for Inhibitors of HP1-beta Chromodomain Interactions with Methylated Histone Tails [AID540317, Type: confirmatory] | chromobox protein homolog 1 [Homo sapiens] [gi:187960037] |  View X | Row No. | 18 | | Structure |
| | Substance | | | SID | 56422357 | | CID | 25102417 | | Outcome | Active | | Potency | 19.9526 [uM] | | BioAssay | HTS for Inhibitors of HP1-beta Chromodomain Interactions with Methylated Histone Tails | | AID | 540317 | | BioAssay type | confirmatory | | Target | chromobox protein homolog 1 [Homo sapiens] [gi:187960037] | | PubMed | | | Data Table |  |
|
| 19 | [SID56422357] | Active | Potency | 25.1189 | qHTS Assay for Inhibitors of Histone Lysine Methyltransferase G9a [AID504332, Type: confirmatory] | euchromatic histone-lysine N-methyltransferase 2 [Homo sapiens] [gi:168985070] |  View X | Row No. | 19 | | Structure |
| | Substance | | | SID | 56422357 | | CID | 25102417 | | Outcome | Active | | Potency | 25.1189 [uM] | | BioAssay | qHTS Assay for Inhibitors of Histone Lysine Methyltransferase G9a | | AID | 504332 | | BioAssay type | confirmatory | | Target | euchromatic histone-lysine N-methyltransferase 2 [Homo sapiens] [gi:168985070] | | PubMed | | | Data Table |  |
|
| 20 | [SID56422357] | Active | Potency | 35.4813 | qHTS for Inhibitors of WRN Helicase [AID651768, Type: confirmatory] | WRN [Homo sapiens] [gi:3719421] |  View X | Row No. | 20 | | Structure |
| | Substance | | | SID | 56422357 | | CID | 25102417 | | Outcome | Active | | Potency | 35.4813 [uM] | | BioAssay | qHTS for Inhibitors of WRN Helicase | | AID | 651768 | | BioAssay type | confirmatory | | Target | WRN [Homo sapiens] [gi:3719421] | | PubMed | | | Data Table |  |
|
| 21 | [SID56422357] | Active | IC50 | 86.9 | Dose Response validation of uHTS RPN11 inhibitor hits using a Thrombin Fluorescence Polarization assay [AID602369, Type: confirmatory] | prothrombin [Bos taurus] [gi:296479639] |  View X | Row No. | 21 | | Structure |
| | Substance | | | SID | 56422357 | | CID | 25102417 | | Outcome | Active | | IC50 | 86.9 [uM] | | BioAssay | Dose Response validation of uHTS RPN11 inhibitor hits using a Thrombin Fluorescence Polarization assay | | AID | 602369 | | BioAssay type | confirmatory | | Target | prothrombin [Bos taurus] [gi:296479639] | | PubMed | | | Data Table |  |
|
| 22 | [SID56422357] | Active | IC50 | 86.9 | Dose Response validation of uHTS RPN11 inhibitor hits using a Thrombin Fluorescence Polarization assay [AID602369, Type: confirmatory] | prothrombin [Bos taurus] [gi:296479639] |  View X | Row No. | 22 | | Structure |
| | Substance | | | SID | 56422357 | | CID | 25102417 | | Outcome | Active | | IC50 | 86.9 [uM] | | BioAssay | Dose Response validation of uHTS RPN11 inhibitor hits using a Thrombin Fluorescence Polarization assay | | AID | 602369 | | BioAssay type | confirmatory | | Target | prothrombin [Bos taurus] [gi:296479639] | | PubMed | | | Data Table |  |
|
| 23 | [SID56422357] | Active | | | Single concentration confirmation of uHTS inhibitor hits from RPN11 in a Fluorescence Polarization assay [AID602318, Type: screening] | PSMD14 protein [Homo sapiens] [gi:16306916] |  View X | Row No. | 23 | | Structure |
| | Substance | | | SID | 56422357 | | CID | 25102417 | | Outcome | Active | | BioAssay | Single concentration confirmation of uHTS inhibitor hits from RPN11 in a Fluorescence Polarization assay | | AID | 602318 | | BioAssay type | screening | | Target | PSMD14 protein [Homo sapiens] [gi:16306916] | | PubMed | | | Data Table |  |
|
| 24 | [SID56422357] | Active | | | uHTS identification of inhibitors of Rpn11 in a Fluorescent Polarization assay [AID588493, Type: screening] | PSMD14 protein [Homo sapiens] [gi:16306916] |  View X | Row No. | 24 | | Structure |
| | Substance | | | SID | 56422357 | | CID | 25102417 | | Outcome | Active | | BioAssay | uHTS identification of inhibitors of Rpn11 in a Fluorescent Polarization assay | | AID | 588493 | | BioAssay type | screening | | Target | PSMD14 protein [Homo sapiens] [gi:16306916] | | PubMed | | | Data Table |  |
|
| 25 | [SID56422357] | Active | | | uHTS Colorimetric assay for identification of inhibitors of Scp-1 [AID493091, Type: screening] | carboxy-terminal domain RNA polymerase II polypeptide A small phosphatase 1 isoform 1 [Homo sapiens] [gi:10864009] |  View X | Row No. | 25 | | Structure |
| | Substance | | | SID | 56422357 | | CID | 25102417 | | Outcome | Active | | BioAssay | uHTS Colorimetric assay for identification of inhibitors of Scp-1 | | AID | 493091 | | BioAssay type | screening | | Target | carboxy-terminal domain RNA polymerase II polypeptide A small phosphatase 1 isoform 1 [Homo sapiens] [gi:10864009] | | PubMed | | | Data Table |  |
|
| 26 | [SID56422357] | Active | | | Single concentration confirmation of uHTS hits for Scp-1 phosphatase using a colorimetric assay [AID540281, Type: screening] | carboxy-terminal domain RNA polymerase II polypeptide A small phosphatase 1 isoform 1 [Homo sapiens] [gi:10864009] |  View X | Row No. | 26 | | Structure |
| | Substance | | | SID | 56422357 | | CID | 25102417 | | Outcome | Active | | BioAssay | Single concentration confirmation of uHTS hits for Scp-1 phosphatase using a colorimetric assay | | AID | 540281 | | BioAssay type | screening | | Target | carboxy-terminal domain RNA polymerase II polypeptide A small phosphatase 1 isoform 1 [Homo sapiens] [gi:10864009] | | PubMed | | | Data Table |  |
|
| 27 | [SID56422357] | Active | Potency | | qHTS for Inhibitors of phosphatidylinositol 5-phosphate 4-kinase (PI5P4K) [AID652105, Type: confirmatory] | |  View X | Row No. | 27 | | Structure |
| | Substance | | | SID | 56422357 | | CID | 25102417 | | Outcome | Active | | Potency | [uM] | | BioAssay | qHTS for Inhibitors of phosphatidylinositol 5-phosphate 4-kinase (PI5P4K) | | AID | 652105 | | BioAssay type | confirmatory | | Target | | | PubMed | | | Data Table |  |
|
| 28 | [SID56422357] | Active | | | TRFRET-based biochemical primary high throughput screening assay to identify inhibitors of 5-meCpG-binding domain protein 2 (MBD2)-DBD binding to methylated oligonucleotide [AID686964, Type: screening] | |  View X | Row No. | 28 | | Structure |
| | Substance | | | SID | 56422357 | | CID | 25102417 | | Outcome | Active | | BioAssay | TRFRET-based biochemical primary high throughput screening assay to identify inhibitors of 5-meCpG-binding domain protein 2 (MBD2)-DBD binding to methylated oligonucleotide | | AID | 686964 | | BioAssay type | screening | | Target | | | PubMed | | | Data Table |  |
|
| 29 | [SID56422357] | Active | | | Single concentration confirmation of DNMT1 inhibitors in a Fluorescent Molecular Beacon assay [AID602385, Type: screening] | DNA (cytosine-5)-methyltransferase 1 isoform b [Homo sapiens] [gi:4503351] |  View X | Row No. | 29 | | Structure |
| | Substance | | | SID | 56422357 | | CID | 25102417 | | Outcome | Active | | BioAssay | Single concentration confirmation of DNMT1 inhibitors in a Fluorescent Molecular Beacon assay | | AID | 602385 | | BioAssay type | screening | | Target | DNA (cytosine-5)-methyltransferase 1 isoform b [Homo sapiens] [gi:4503351] | | PubMed | | | Data Table |  |
|
| 30 | [SID56422357] | Active | | | Single concentration confirmation of DNMT1 inhibitors in a Fluorescent Molecular Beacon assay [AID602385, Type: screening] | DNA (cytosine-5)-methyltransferase 1 isoform b [Homo sapiens] [gi:4503351] |  View X | Row No. | 30 | | Structure |
| | Substance | | | SID | 56422357 | | CID | 25102417 | | Outcome | Active | | BioAssay | Single concentration confirmation of DNMT1 inhibitors in a Fluorescent Molecular Beacon assay | | AID | 602385 | | BioAssay type | screening | | Target | DNA (cytosine-5)-methyltransferase 1 isoform b [Homo sapiens] [gi:4503351] | | PubMed | | | Data Table |  |
|
| 31 | [SID56422357] | Active | | | uHTS identification of SUMO1-mediated protein-protein interactions [AID602429, Type: screening] | SUMO-1 [Homo sapiens] [gi:1762973] |  View X | Row No. | 31 | | Structure |
| | Substance | | | SID | 56422357 | | CID | 25102417 | | Outcome | Active | | BioAssay | uHTS identification of SUMO1-mediated protein-protein interactions | | AID | 602429 | | BioAssay type | screening | | Target | SUMO-1 [Homo sapiens] [gi:1762973] | | PubMed | | | Data Table |  |
|
| 32 | [SID56422357] | Active | | | Fluorescence-based biochemical primary high throughput assay to identify inhibitors of T-cell receptor (TCR)-CD3 interaction using a TAMRA-labeled TCR probe [AID651800, Type: screening] | TCRAV4S1 [Homo sapiens] [gi:2358024] |  View X | Row No. | 32 | | Structure |
| | Substance | | | SID | 56422357 | | CID | 25102417 | | Outcome | Active | | BioAssay | Fluorescence-based biochemical primary high throughput assay to identify inhibitors of T-cell receptor (TCR)-CD3 interaction using a TAMRA-labeled TCR probe | | AID | 651800 | | BioAssay type | screening | | Target | TCRAV4S1 [Homo sapiens] [gi:2358024] | | PubMed | | | Data Table |  |
|
| 33 | [SID56422357] | Active | | | uHTS identification of DNMT1 inhibitors in a Fluorescent Molecular Beacon assay [AID588458, Type: screening] | DNA (cytosine-5)-methyltransferase 1 isoform b [Homo sapiens] [gi:4503351] |  View X | Row No. | 33 | | Structure |
| | Substance | | | SID | 56422357 | | CID | 25102417 | | Outcome | Active | | BioAssay | uHTS identification of DNMT1 inhibitors in a Fluorescent Molecular Beacon assay | | AID | 588458 | | BioAssay type | screening | | Target | DNA (cytosine-5)-methyltransferase 1 isoform b [Homo sapiens] [gi:4503351] | | PubMed | | | Data Table |  |
|
| 34 | [SID56422357] | Active | | | uHTS identification of DNMT1 inhibitors in a Fluorescent Molecular Beacon assay [AID588458, Type: screening] | DNA (cytosine-5)-methyltransferase 1 isoform b [Homo sapiens] [gi:4503351] |  View X | Row No. | 34 | | Structure |
| | Substance | | | SID | 56422357 | | CID | 25102417 | | Outcome | Active | | BioAssay | uHTS identification of DNMT1 inhibitors in a Fluorescent Molecular Beacon assay | | AID | 588458 | | BioAssay type | screening | | Target | DNA (cytosine-5)-methyltransferase 1 isoform b [Homo sapiens] [gi:4503351] | | PubMed | | | Data Table |  |
|
| 35 | [SID56422357] | Active | | | Antagonist of Human D 1 Dopamine Receptor: qHTS [AID504652, Type: screening] | D(1A) dopamine receptor [Homo sapiens] [gi:4503383] |  View X | Row No. | 35 | | Structure |
| | Substance | | | SID | 56422357 | | CID | 25102417 | | Outcome | Active | | BioAssay | Antagonist of Human D 1 Dopamine Receptor: qHTS | | AID | 504652 | | BioAssay type | screening | | Target | D(1A) dopamine receptor [Homo sapiens] [gi:4503383] | | PubMed | | | Data Table |  |
|
| 36 | [SID56422357] | Active | | | Antagonist of Human D 1 Dopamine Receptor: qHTS [AID504652, Type: screening] | D(1A) dopamine receptor [Homo sapiens] [gi:4503383] |  View X | Row No. | 36 | | Structure |
| | Substance | | | SID | 56422357 | | CID | 25102417 | | Outcome | Active | | BioAssay | Antagonist of Human D 1 Dopamine Receptor: qHTS | | AID | 504652 | | BioAssay type | screening | | Target | D(1A) dopamine receptor [Homo sapiens] [gi:4503383] | | PubMed | | | Data Table |  |
|
| 37 | [SID56422357] | Active | | | Antagonist of Human D 1 Dopamine Receptor: qHTS [AID504652, Type: screening] | D(1A) dopamine receptor [Homo sapiens] [gi:4503383] |  View X | Row No. | 37 | | Structure |
| | Substance | | | SID | 56422357 | | CID | 25102417 | | Outcome | Active | | BioAssay | Antagonist of Human D 1 Dopamine Receptor: qHTS | | AID | 504652 | | BioAssay type | screening | | Target | D(1A) dopamine receptor [Homo sapiens] [gi:4503383] | | PubMed | | | Data Table |  |
|
| 38 | [SID56422357] | Active | | | Antagonist of Human D 1 Dopamine Receptor: qHTS [AID504652, Type: screening] | D(1A) dopamine receptor [Homo sapiens] [gi:4503383] |  View X | Row No. | 38 | | Structure |
| | Substance | | | SID | 56422357 | | CID | 25102417 | | Outcome | Active | | BioAssay | Antagonist of Human D 1 Dopamine Receptor: qHTS | | AID | 504652 | | BioAssay type | screening | | Target | D(1A) dopamine receptor [Homo sapiens] [gi:4503383] | | PubMed | | | Data Table |  |
|
| 39 | [SID56422357] | Unspecified | Potency | | qHTS for Inhibitors of Human Acid Sphingomyelinase Assay: Native Substrate [AID624178, Type: confirmatory] | acid sphingomyelinase [Homo sapiens] [gi:179095] |  View X | Row No. | 39 | | Structure |
| | Substance | | | SID | 56422357 | | CID | 25102417 | | Outcome | Unspecified | | Potency | [uM] | | BioAssay | qHTS for Inhibitors of Human Acid Sphingomyelinase Assay: Native Substrate | | AID | 624178 | | BioAssay type | confirmatory | | Target | acid sphingomyelinase [Homo sapiens] [gi:179095] | | PubMed | | | Data Table |  |
|
| 40 | [SID56422357] | Unspecified | Potency | | qHTS for Inhibitors of Human Acid Sphingomyelinase Assay: Native Substrate [AID624178, Type: confirmatory] | acid sphingomyelinase [Homo sapiens] [gi:179095] |  View X | Row No. | 40 | | Structure |
| | Substance | | | SID | 56422357 | | CID | 25102417 | | Outcome | Unspecified | | Potency | [uM] | | BioAssay | qHTS for Inhibitors of Human Acid Sphingomyelinase Assay: Native Substrate | | AID | 624178 | | BioAssay type | confirmatory | | Target | acid sphingomyelinase [Homo sapiens] [gi:179095] | | PubMed | | | Data Table |  |
|
| 41 | [SID56422357] | Inactive | Potency | 4.6535 | Primary qHTS for delayed death inhibitors of the malarial parasite plastid, 48 hour incubation [AID504832, Type: confirmatory] | |  View X | Row No. | 41 | | Structure |
| | Substance | | | SID | 56422357 | | CID | 25102417 | | Outcome | Inactive | | Potency | 4.6535 [uM] | | BioAssay | Primary qHTS for delayed death inhibitors of the malarial parasite plastid, 48 hour incubation | | AID | 504832 | | BioAssay type | confirmatory | | Target | | | PubMed | | | Data Table |  |
|
| 42 | [SID56422357] | Inactive | IC50 | 66.6 | Dose response confirmation of uHTS inhibitor hits of SUMO1-mediated protein-protein interactions using a fluorescence polarization assay [AID624382, Type: confirmatory] | SUMO-1 [Homo sapiens] [gi:1762973] |  View X | Row No. | 42 | | Structure |
| | Substance | | | SID | 56422357 | | CID | 25102417 | | Outcome | Inactive | | IC50 | 66.6 [uM] | | BioAssay | Dose response confirmation of uHTS inhibitor hits of SUMO1-mediated protein-protein interactions using a fluorescence polarization assay | | AID | 624382 | | BioAssay type | confirmatory | | Target | SUMO-1 [Homo sapiens] [gi:1762973] | | PubMed | | | Data Table |  |
|
| 43 | [SID56422357] | Inactive | IC50 | 99 | Dose response validation of uHTS inhibitor hits from DNMT1 for spectral interference using a Fluorescent Molecular Beacon assay [AID602382, Type: confirmatory] | |  View X | Row No. | 43 | | Structure |
| | Substance | | | SID | 56422357 | | CID | 25102417 | | Outcome | Inactive | | IC50 | 99 [uM] | | BioAssay | Dose response validation of uHTS inhibitor hits from DNMT1 for spectral interference using a Fluorescent Molecular Beacon assay | | AID | 602382 | | BioAssay type | confirmatory | | Target | | | PubMed | | | Data Table |  |
|
| 44 | [SID56422357] | Inactive | | | Single concentration validation of uHTS inhibitor hits from DNMT1 for spectral interference using a Fluorescent Molecular Beacon assay [AID602387, Type: screening] | |  View X | Row No. | 44 | | Structure |
| | Substance | | | SID | 56422357 | | CID | 25102417 | | Outcome | Inactive | | BioAssay | Single concentration validation of uHTS inhibitor hits from DNMT1 for spectral interference using a Fluorescent Molecular Beacon assay | | AID | 602387 | | BioAssay type | screening | | Target | | | PubMed | | | Data Table |  |
|
| 45 | [SID56422357] | Inactive | | | uHTS identification of small molecule inhibitors of the mitochondrial permeability transition pore via an absorbance assay [AID602449, Type: screening] | |  View X | Row No. | 45 | | Structure |
| | Substance | | | SID | 56422357 | | CID | 25102417 | | Outcome | Inactive | | BioAssay | uHTS identification of small molecule inhibitors of the mitochondrial permeability transition pore via an absorbance assay | | AID | 602449 | | BioAssay type | screening | | Target | | | PubMed | | | Data Table |  |
|
| 46 | [SID56422357] | Inactive | | | Small molecule inhibitors of miR122 Measured in Cell-Based System Using Plate Reader - 2144-01_Activator_SinglePoint_HTS_Activity [AID623901, Type: screening] | |  View X | Row No. | 46 | | Structure |
| | Substance | | | SID | 56422357 | | CID | 25102417 | | Outcome | Inactive | | BioAssay | Small molecule inhibitors of miR122 Measured in Cell-Based System Using Plate Reader - 2144-01_Activator_SinglePoint_HTS_Activity | | AID | 623901 | | BioAssay type | screening | | Target | | | PubMed | | | Data Table |  |
|
| 47 | [SID56422357] | Inactive | | | HTS to identify compounds that promote myeloid differentiation with MLPCN compound set [AID624256, Type: screening] | |  View X | Row No. | 47 | | Structure |
| | Substance | | | SID | 56422357 | | CID | 25102417 | | Outcome | Inactive | | BioAssay | HTS to identify compounds that promote myeloid differentiation with MLPCN compound set | | AID | 624256 | | BioAssay type | screening | | Target | | | PubMed | | | Data Table |  |
|
| 48 | [SID56422357] | Inactive | | | Whole cell Yeast HTS to identify compounds modulating the fidelity of the start codon recognition in eukaryotes. Measured in Whole Organism System Using Plate Reader - 2155-01_Other_SinglePoint_HTS_Activity [AID602363, Type: screening] | |  View X | Row No. | 48 | | Structure |
| | Substance | | | SID | 56422357 | | CID | 25102417 | | Outcome | Inactive | | BioAssay | Whole cell Yeast HTS to identify compounds modulating the fidelity of the start codon recognition in eukaryotes. Measured in Whole Organism System Using Plate Reader - 2155-01_Other_SinglePoint_HTS_Activity | | AID | 602363 | | BioAssay type | screening | | Target | | | PubMed | | | Data Table |  |
|
| 49 | [SID56422357] | Inactive | Potency | | qHTS of GLP-1 Receptor Inverse Agonists: Cytotox Screen [AID624418, Type: confirmatory] | |  View X | Row No. | 49 | | Structure |
| | Substance | | | SID | 56422357 | | CID | 25102417 | | Outcome | Inactive | | Potency | [uM] | | BioAssay | qHTS of GLP-1 Receptor Inverse Agonists: Cytotox Screen | | AID | 624418 | | BioAssay type | confirmatory | | Target | | | PubMed | | | Data Table |  |
|
| 50 | [SID56422357] | Inactive | | | Counterscreen of compound fluorescence effects on High-throughput multiplex microsphere screening for inhibitors of toxin protease [AID624483, Type: screening] | |  View X | Row No. | 50 | | Structure |
| | Substance | | | SID | 56422357 | | CID | 25102417 | | Outcome | Inactive | | BioAssay | Counterscreen of compound fluorescence effects on High-throughput multiplex microsphere screening for inhibitors of toxin protease | | AID | 624483 | | BioAssay type | screening | | Target | | | PubMed | | | Data Table |  |
|